Vontobel Holding’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,710
Closed -$208K 1155
2024
Q4
$208K Sell
1,710
-93
-5% -$11.3K ﹤0.01% 1006
2024
Q3
$225K Sell
1,803
-3,281
-65% -$410K ﹤0.01% 983
2024
Q2
$803K Sell
5,084
-19,316
-79% -$3.05M ﹤0.01% 625
2024
Q1
$3.16M Sell
24,400
-878
-3% -$114K 0.03% 378
2023
Q4
$2.44M Buy
25,278
+2,863
+13% +$276K 0.02% 403
2023
Q3
$2.72M Sell
22,415
-798
-3% -$96.7K 0.03% 375
2023
Q2
$2.66M Sell
23,213
-3,898
-14% -$446K 0.02% 392
2023
Q1
$3.74M Sell
27,111
-1,555
-5% -$214K 0.03% 325
2022
Q4
$3.62M Buy
28,666
+7,899
+38% +$998K 0.04% 332
2022
Q3
$2.3M Buy
20,767
+1,638
+9% +$181K 0.03% 375
2022
Q2
$1.47M Sell
19,129
-250
-1% -$19.3K 0.02% 447
2022
Q1
$1.51M Sell
19,379
-1,156
-6% -$90.3K 0.01% 497
2021
Q4
$1.85M Buy
20,535
+3,165
+18% +$285K 0.02% 461
2021
Q3
$1.61M Buy
17,370
+1,064
+7% +$98.4K 0.01% 494
2021
Q2
$1.27M Buy
16,306
+4,007
+33% +$312K 0.01% 542
2021
Q1
$917K Sell
12,299
-164
-1% -$12.2K 0.01% 547
2020
Q4
$1.19M Buy
+12,463
New +$1.19M 0.01% 466